|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Premenstrual Syndrome | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Syndrome | |||||
| 3 | More general conditions related to this trial | ||||
| Disease | |||||
| Menstruation Disturbances | |||||
| Pathologic Processes | |||||
| 4 | Additional drug interventions recognized in this trial | ||||
| Vitamin D | |||||
| 5 | More general drug interventions related to this trial | ||||
| Bone Density Conservation Agents | |||||
| Growth Substances | |||||
| Micronutrients | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Vitamins | |||||
| 6 | Sponsors listed in this trial | ||||
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | |||||
| National Institute of Mental Health (NIMH) | |||||